Michael McCaman

1.2k total citations
28 papers, 953 citations indexed

About

Michael McCaman is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Michael McCaman has authored 28 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Genetics and 5 papers in Oncology. Recurrent topics in Michael McCaman's work include Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and Bacteriophages and microbial interactions (4 papers). Michael McCaman is often cited by papers focused on Virus-based gene therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and Bacteriophages and microbial interactions (4 papers). Michael McCaman collaborates with scholars based in United States, Netherlands and Germany. Michael McCaman's co-authors include Ernö Pungor, William S. Hancock, F Fawaz, Xiaoyang Zheng, Jeffrey D. Gabe, Merna Villarejo, William H. Andrews, Jon A. Rowley, Scott R. Burger and Jessica Carmen and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Journal of Virology.

In The Last Decade

Michael McCaman

28 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael McCaman United States 16 526 267 171 128 92 28 953
Rose G. Mage United States 30 1.4k 2.6× 310 1.2× 119 0.7× 79 0.6× 76 0.8× 145 2.9k
Otto-Wilhelm Merten France 17 864 1.6× 596 2.2× 202 1.2× 137 1.1× 50 0.5× 27 1.2k
Terry A. Potter United States 28 832 1.6× 322 1.2× 394 2.3× 38 0.3× 33 0.4× 70 3.3k
Pratik Singh United States 17 764 1.5× 231 0.9× 85 0.5× 152 1.2× 31 0.3× 37 1.6k
M. Nedim Ince United States 13 924 1.8× 257 1.0× 110 0.6× 32 0.3× 86 0.9× 23 1.6k
Manuela Mura Italy 21 746 1.4× 162 0.6× 57 0.3× 58 0.5× 260 2.8× 48 1.5k
Edzard Spillner Germany 28 346 0.7× 180 0.7× 47 0.3× 38 0.3× 76 0.8× 80 2.3k
Sherri L. Motzel United States 14 477 0.9× 318 1.2× 160 0.9× 27 0.2× 68 0.7× 21 1.1k
Nancy B. Amaro-Mugridge Australia 13 599 1.1× 136 0.5× 87 0.5× 211 1.6× 16 0.2× 16 1.2k
Claudia Pérez‐Martínez Spain 20 913 1.7× 121 0.5× 105 0.6× 23 0.2× 39 0.4× 81 1.7k

Countries citing papers authored by Michael McCaman

Since Specialization
Citations

This map shows the geographic impact of Michael McCaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael McCaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael McCaman more than expected).

Fields of papers citing papers by Michael McCaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael McCaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael McCaman. The network helps show where Michael McCaman may publish in the future.

Co-authorship network of co-authors of Michael McCaman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael McCaman. A scholar is included among the top collaborators of Michael McCaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael McCaman. Michael McCaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braatz, James A., et al.. (2014). Quantitation of residual trypsin in cell-based therapeutics using immobilized α-1-antitrypsin or SBTI in an ELISA format. Journal of Immunological Methods. 417. 131–133. 14 indexed citations
2.
Clarke, Dominic, Jon A. Rowley, Michael McCaman, et al.. (2012). Managing particulates in cellular therapy. Cytotherapy. 14(9). 1032–1040. 10 indexed citations
3.
Carmen, Jessica, Scott R. Burger, Michael McCaman, & Jon A. Rowley. (2011). Developing Assays to Address Identity, Potency, Purity and Safety: Cell Characterization in Cell Therapy Process Development. Regenerative Medicine. 7(1). 85–100. 67 indexed citations
4.
Tao, Yu, et al.. (2006). Precise and comparative pegylation analysis by microfluidics and mass spectrometry. Analytical Biochemistry. 359(1). 54–62. 18 indexed citations
6.
Rosser, Mary P., Wei Xia, Michael McCaman, et al.. (2005). Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system. Protein Expression and Purification. 40(2). 237–243. 52 indexed citations
7.
Fawaz, F, et al.. (2005). A potency assay for a replication incompetent adenovirus type 5 carrying a human fgf-4 gene. Analytical Biochemistry. 342(1). 34–44. 1 indexed citations
8.
McCaman, Michael, et al.. (2003). Brachyspira hyodysenteriae contains eight linked gene copies related to an expressed 39-kDa surface protein. Microbes and Infection. 5(1). 1–6. 10 indexed citations
10.
Peters, Antoine H.F.M., David A. Roth, David M. Roth, et al.. (2001). Absence of Germline Infection in Male Mice Following Intraventricular Injection of Adenovirus. Molecular Therapy. 4(6). 603–613. 27 indexed citations
11.
McCaman, Michael, et al.. (2001). Analysis of Recombinant Adenoviruses Using an Integrated Microfluidic Chip-Based System. Analytical Biochemistry. 291(2). 262–268. 17 indexed citations
12.
McCaman, Michael, et al.. (1999). Quantitation of Adenovirus DNA and Virus Particles with the PicoGreen Fluorescent Dye. Analytical Biochemistry. 274(2). 283–288. 76 indexed citations
13.
Light, David R., Charles B. Glaser, Eric Blasko, et al.. (1999). The interaction of thrombomodulin with Ca2+. European Journal of Biochemistry. 262(2). 522–533. 25 indexed citations
14.
Lehmberg, Elisabeth, John A. Chakel, Michael McCaman, et al.. (1999). Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome. Journal of Chromatography B Biomedical Sciences and Applications. 732(2). 411–423. 69 indexed citations
16.
McCaman, Michael, et al.. (1998). Affinity Binding of a Vampire Bat Plasminogen Activator to SEC Resins. Protein Expression and Purification. 12(1). 111–121. 1 indexed citations
17.
McCaman, Michael. (1989). Fragments of prochymosin produced in Escherichia coli form insoluble inclusion bodies. Journal of Bacteriology. 171(2). 1225–1227. 11 indexed citations
18.
Kuhn, Irene, Leland S. Paul, Jeffrey D. Gabe, et al.. (1988). Characterization of a surface antigen of Eimeria tenella sporozoites and synthesis from a cloned cDNA in Escherichia coli. Molecular and Biochemical Parasitology. 28(3). 235–247. 54 indexed citations
19.
McCaman, Michael, et al.. (1988). Unusual zymogen‐processing properties of a mutated form of prochymosin. Proteins Structure Function and Bioinformatics. 3(4). 256–261. 8 indexed citations
20.
McCaman, Michael, William H. Andrews, & James G. Files. (1985). Enzymatic properties and processing of bovine prochymosin synthesized in Escherichia coli. Journal of Biotechnology. 2(3-4). 177–190. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026